These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 31969492)

  • 1. SENP1 is a crucial promotor for hepatocellular carcinoma through deSUMOylation of UBE2T.
    Tao Y; Li R; Shen C; Li J; Zhang Q; Ma Z; Wang F; Wang Z
    Aging (Albany NY); 2020 Jan; 12(2):1563-1576. PubMed ID: 31969492
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UBE2T-regulated H2AX monoubiquitination induces hepatocellular carcinoma radioresistance by facilitating CHK1 activation.
    Sun J; Zhu Z; Li W; Shen M; Cao C; Sun Q; Guo Z; Liu L; Wu D
    J Exp Clin Cancer Res; 2020 Oct; 39(1):222. PubMed ID: 33087136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LncRNA FRMD6-AS1 promotes hepatocellular carcinoma cell migration and stemness by regulating SENP1/HIF-1α axis.
    Sun W; Lei X; Lu Q; Wu Q; Ma Q; Huang D; Zhang Y
    Pathol Res Pract; 2023 Mar; 243():154377. PubMed ID: 36827886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ubiquitin-conjugating enzyme E2T knockdown suppresses hepatocellular tumorigenesis
    Guo J; Wang M; Wang JP; Wu CX
    World J Gastroenterol; 2019 Nov; 25(43):6386-6403. PubMed ID: 31798276
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UBE2T promotes hepatocellular carcinoma cell growth via ubiquitination of p53.
    Liu LP; Yang M; Peng QZ; Li MY; Zhang YS; Guo YH; Chen Y; Bao SY
    Biochem Biophys Res Commun; 2017 Nov; 493(1):20-27. PubMed ID: 28935368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. UBE2T promotes nasopharyngeal carcinoma cell proliferation, invasion, and metastasis by activating the AKT/GSK3β/β-catenin pathway.
    Hu W; Xiao L; Cao C; Hua S; Wu D
    Oncotarget; 2016 Mar; 7(12):15161-72. PubMed ID: 26943030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1-involved EMT in hepatocellular carcinoma.
    Yang Y; Huang L; Zhang N; Deng YN; Cao X; Liang Y; Hou H; Luo Y; Yang Y; Li Q; Liang S
    Cell Commun Signal; 2024 Apr; 22(1):206. PubMed ID: 38566133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBE2T-mediated Akt ubiquitination and Akt/β-catenin activation promotes hepatocellular carcinoma development by increasing pyrimidine metabolism.
    Zhu Z; Cao C; Zhang D; Zhang Z; Liu L; Wu D; Sun J
    Cell Death Dis; 2022 Feb; 13(2):154. PubMed ID: 35169125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SENP1-Mediated deSUMOylation Regulates the Tumor Remodeling of Glioma Stem Cells Under Hypoxic Stress.
    Wen P; Li H; Liu L; Liu X; Xu Z; Dong J
    Technol Cancer Res Treat; 2024; 23():15330338241257490. PubMed ID: 38803001
    [No Abstract]   [Full Text] [Related]  

  • 10. SENP1 promotes hypoxia-induced cancer stemness by HIF-1α deSUMOylation and SENP1/HIF-1α positive feedback loop.
    Cui CP; Wong CC; Kai AK; Ho DW; Lau EY; Tsui YM; Chan LK; Cheung TT; Chok KS; Chan ACY; Lo RC; Lee JM; Lee TK; Ng IOL
    Gut; 2017 Dec; 66(12):2149-2159. PubMed ID: 28258134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. METTL3-mediated m
    Li B; Xiong X; Xu J; Peng D; Nie G; Wen N; Wang Y; Lu J
    Oncogene; 2024 Mar; 43(14):1050-1062. PubMed ID: 38374407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SENP1 regulates hepatocyte growth factor-induced migration and epithelial-mesenchymal transition of hepatocellular carcinoma.
    Zhang W; Sun H; Shi X; Wang H; Cui C; Xiao F; Wu C; Guo X; Wang L
    Tumour Biol; 2016 Jun; 37(6):7741-8. PubMed ID: 26695141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SUMO-Specific Cysteine Protease 1 Promotes Epithelial Mesenchymal Transition of Prostate Cancer Cells via Regulating SMAD4 deSUMOylation.
    Zhang X; Wang H; Wang H; Xiao F; Seth P; Xu W; Jia Q; Wu C; Yang Y; Wang L
    Int J Mol Sci; 2017 Apr; 18(4):. PubMed ID: 28417919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interplay of UBE2T and Mule in regulating Wnt/β-catenin activation to promote hepatocellular carcinoma progression.
    Ho NPY; Leung CON; Wong TL; Lau EYT; Lei MML; Mok EHK; Leung HW; Tong M; Ng IOL; Yun JP; Ma S; Lee TKW
    Cell Death Dis; 2021 Feb; 12(2):148. PubMed ID: 33542213
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SENP1 promotes triple-negative breast cancer invasion and metastasis via enhancing CSN5 transcription mediated by GATA1 deSUMOylation.
    Gao Y; Wang R; Liu J; Zhao K; Qian X; He X; Liu H
    Int J Biol Sci; 2022; 18(5):2186-2201. PubMed ID: 35342335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. UBE2T promotes β-catenin nuclear translocation in hepatocellular carcinoma through MAPK/ERK-dependent activation.
    Lioulia E; Mokos P; Panteris E; Dafou D
    Mol Oncol; 2022 Apr; 16(8):1694-1713. PubMed ID: 34614271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Overexpression of ubiquitin-conjugating enzyme 2T induces radiotherapy resistance in hepatocellular carcinoma by enriching regulatory T cells in the tumor microenvironment].
    He X; Xiong S; Zhu Z; Sun J; Cao C; Wang H
    Nan Fang Yi Ke Da Xue Xue Bao; 2024 Jun; 44(6):1149-1158. PubMed ID: 38977345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SENP1 is required for the growth, migration, and survival of human adipose-derived stem cells.
    Wu Y; Yu B; Wang M
    Adipocyte; 2021 Dec; 10(1):38-47. PubMed ID: 33371766
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of ubiquitin-conjugating enzyme E2T (UBE2T) predicts poor prognosis and promotes hepatocellular carcinoma progression.
    Ren X; Li A; Ying E; Fang J; Li M; Yu J
    Bioengineered; 2021 Dec; 12(1):1530-1542. PubMed ID: 33934686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N6-methyladenosine-modified SENP1, identified by IGF2BP3, is a novel molecular marker in acute myeloid leukemia and aggravates progression by activating AKT signal via de-SUMOylating HDAC2.
    Wen D; Xiao H; Gao Y; Zeng H; Deng J
    Mol Cancer; 2024 May; 23(1):116. PubMed ID: 38822351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.